These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 16701103

  • 21. Effects of esmolol on patients with left ventricular dysfunction.
    Iskandrian AS, Bemis CE, Hakki AH, Panidis I, Heo J, Toole JG, Hua TA, Allin D, Kane-Marsch S.
    J Am Coll Cardiol; 1986 Jul; 8(1):225-31. PubMed ID: 2872244
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Esmolol in anesthesiology: pharmacology and indications].
    Fita G, Gomar C, Rovira I.
    Rev Esp Anestesiol Reanim; 1999 Nov; 46(9):404-14. PubMed ID: 10613078
    [Abstract] [Full Text] [Related]

  • 24. Acute hemodynamic effects of beta-blockers in patients with severe congestive heart failure: comparison of celiprolol and esmolol.
    Felix SB, Stangl V, Kieback A, Doerffel W, Staudt A, Wernecke KD, Baumann G, Stangl K.
    J Cardiovasc Pharmacol; 2001 Nov; 38(5):666-71. PubMed ID: 11602813
    [Abstract] [Full Text] [Related]

  • 25. Beta-blocker use in severe sepsis and septic shock: a systematic review.
    Sanfilippo F, Santonocito C, Morelli A, Foex P.
    Curr Med Res Opin; 2015 Nov; 31(10):1817-25. PubMed ID: 26121122
    [Abstract] [Full Text] [Related]

  • 26. The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting.
    Arar C, Colak A, Alagol A, Uzer SS, Ege T, Turan N, Duran E, Pamukcu Z.
    Eur J Anaesthesiol; 2007 Oct; 24(10):826-31. PubMed ID: 17583595
    [Abstract] [Full Text] [Related]

  • 27. Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock.
    Wei C, Louis H, Schmitt M, Albuisson E, Orlowski S, Levy B, Kimmoun A.
    Crit Care; 2016 Dec 21; 20(1):407. PubMed ID: 27998289
    [Abstract] [Full Text] [Related]

  • 28. [Effects on the hemodynamics and myocardial contractility of 2 beta blockader agents: propranolol and proctolol].
    Sanguinetti M, Picchio FM, Maresta A, Branzi A, Baccarani G, Binetti G.
    G Ital Cardiol; 1972 Dec 21; 2(5):710-9. PubMed ID: 4404053
    [No Abstract] [Full Text] [Related]

  • 29. Efficacy and Safety of Esmolol in Treatment of Patients with Septic Shock.
    Du W, Wang XT, Long Y, Liu DW.
    Chin Med J (Engl); 2016 Jul 20; 129(14):1658-65. PubMed ID: 27411452
    [Abstract] [Full Text] [Related]

  • 30. Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats.
    Suzuki T, Morisaki H, Serita R, Yamamoto M, Kotake Y, Ishizaka A, Takeda J.
    Crit Care Med; 2005 Oct 20; 33(10):2294-301. PubMed ID: 16215384
    [Abstract] [Full Text] [Related]

  • 31. Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
    Ignarro LJ.
    Cardiovasc Ther; 2008 Oct 20; 26(2):115-34. PubMed ID: 18485134
    [Abstract] [Full Text] [Related]

  • 32. Circulatory responses of the dog to acute isovolumic anaemia in the presence of high-grade adrenergic beta-receptor blockade.
    Clarke TN, Foëx P, Roberts JG, Saner CA, Bennett MJ.
    Br J Anaesth; 1980 Mar 20; 52(3):337-41. PubMed ID: 7370150
    [Abstract] [Full Text] [Related]

  • 33. The use of esmolol in whole-body hyperthermia: cardiovascular effects.
    Berry JM, Michalsen A, Nagle V, Bull JM.
    Int J Hyperthermia; 1997 Mar 20; 13(3):261-8. PubMed ID: 9222810
    [Abstract] [Full Text] [Related]

  • 34. β1-Blockade increases maximal apnea duration in elite breath-hold divers.
    Hoiland RL, Ainslie PN, Bain AR, MacLeod DB, Stembridge M, Drvis I, Madden D, Barak O, MacLeod DM, Dujic Z.
    J Appl Physiol (1985); 2017 Apr 01; 122(4):899-906. PubMed ID: 27125844
    [Abstract] [Full Text] [Related]

  • 35. beta-Adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis.
    Schmitz D, Wilsenack K, Lendemanns S, Schedlowski M, Oberbeck R.
    Resuscitation; 2007 Feb 01; 72(2):286-94. PubMed ID: 17118511
    [Abstract] [Full Text] [Related]

  • 36. Beta-receptor blockade, physical activity, and metabolism.
    Lohmann FW, Loesment WA, Kaehler H.
    J Cardiovasc Pharmacol; 1990 Feb 01; 16 Suppl 5():S45-52. PubMed ID: 11527136
    [Abstract] [Full Text] [Related]

  • 37. [Hemodynamic effects of dipyridamole (Persantin) following beta-blockade in coronary failure].
    Kinsbergen M, Friedemann M.
    Schweiz Med Wochenschr; 1973 Feb 24; 103(8):312-5. PubMed ID: 4144418
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Effect of esmolol on cardiovascular responses induced by scopolamine butylbromide].
    Suzuki S, Nonaka A, Abe F.
    Masui; 2005 Nov 24; 54(11):1277-81. PubMed ID: 16296368
    [Abstract] [Full Text] [Related]

  • 40. Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease.
    Stewart RA, Raffel OC, Kerr AJ, Gabriel R, Zeng I, Young AA, Cowan BR.
    Circulation; 2008 Sep 02; 118(10):1041-6. PubMed ID: 18725484
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.